Vanberra Signal

Encora Therapeutics

Curated by Signal

Developer of smart devices for the treatment of neurological movement disorders

Overview

Encora Therapeutics is a developer of smart devices for the treatment of neurological movement disorders. It provides solutions for the people suffering from hand tremors, Parkinson's diseases, essential tremor, and others. It uses wearable technology, signal processing, reinforcement learning, and patient sensing to provide personalized, non-invasive remedies for patients with neurological movement disorders.

Key facts

Founded
2018

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Portfolio of PC-based cardiology and respiratory products

    Life Sciences TechnologySaint Paul, United States
  • Provider of application for sequence analysis and molecular biology data management

    Life Sciences TechnologyMonte Rio, United States
  • Platform offering AI designed antibodies

    Life Sciences TechnologyNew York, United States

About Encora Therapeutics

What does Encora Therapeutics do?

Encora Therapeutics is a developer of smart devices for the treatment of neurological movement disorders.

Where is Encora Therapeutics headquartered?

Encora Therapeutics is headquartered in Cambridge, United States.

When was Encora Therapeutics founded?

Encora Therapeutics was founded in 2018.

Which sector is Encora Therapeutics in?

Encora Therapeutics operates in Life Sciences Technology.

Who are Encora Therapeutics's competitors?

Companies similar to Encora Therapeutics include QRS Diagnostic, Molquest, and Quine Biologics.